-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Initiates Coverage On ArriVent BioPharma with Overweight Rating

Benzinga·12/23/2025 12:56:07
Listen to the news
Cantor Fitzgerald analyst Li Watsek initiates coverage on ArriVent BioPharma (NASDAQ:AVBP) with a Overweight rating.